Lyophilized and Stabilized Live Attenuated Formulated Vaccine Against Tularemia

Abstract

A lyophilized stabilized formulation containing a live attenuated vaccine strain against tularemia. The method includes supplying the immunogenic agent comprising Fn-igIDOAg.sup.FTT and subjecting the immunogenic agent to lyophilization and recovering a lyophilized and stabilized form of such immunogenic agent.

Patent Number
12,343,431
Date Of Issue
Inventors

Kenneth H. Carson; Spring M. Cabiness; Amy M. De Los Santos; Karl Klose